Safety and antiretroviral effects of combined didanosine and stavudine therapy in HIV-infected individuals with CD4 counts of 200 to 500 cells/mm3. [electronic resource]
Producer: 19991028Description: 39-48 p. digitalISSN:- 1525-4135
- Adult
- Aged
- Anti-HIV Agents -- adverse effects
- CD4 Lymphocyte Count
- Didanosine -- adverse effects
- Dose-Response Relationship, Drug
- Double-Blind Method
- Drug Therapy, Combination
- Female
- HIV -- drug effects
- HIV Infections -- drug therapy
- Humans
- Male
- Middle Aged
- Peripheral Nervous System Diseases -- chemically induced
- RNA, Viral -- blood
- Stavudine -- adverse effects
- Viral Load
- Virus Replication -- drug effects
- Weight Gain
No physical items for this record
Publication Type: Clinical Trial; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.